Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ocular Motility Disorders | 1 | 2023 | 38 | 0.870 |
Why?
|
| Strabismus | 1 | 2023 | 47 | 0.870 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2007 | 12 | 0.280 |
Why?
|
| Cranial Nerve Diseases | 1 | 2007 | 26 | 0.270 |
Why?
|
| Acetazolamide | 1 | 2023 | 30 | 0.220 |
Why?
|
| Eye Movements | 1 | 2023 | 69 | 0.220 |
Why?
|
| Calcium Channels | 1 | 2023 | 158 | 0.210 |
Why?
|
| Ataxia | 1 | 2023 | 168 | 0.200 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 9 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 25 | 0.190 |
Why?
|
| Myasthenia Gravis | 1 | 2021 | 71 | 0.180 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 55 | 0.170 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 26 | 0.160 |
Why?
|
| Seizures | 1 | 2023 | 871 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 1265 | 0.150 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 214 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 485 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 647 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1528 | 0.110 |
Why?
|
| Infant | 3 | 2023 | 12339 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3083 | 0.090 |
Why?
|
| Mutation | 2 | 2021 | 5773 | 0.090 |
Why?
|
| Facial Paralysis | 1 | 2007 | 36 | 0.070 |
Why?
|
| Male | 5 | 2023 | 60034 | 0.070 |
Why?
|
| Deafness | 1 | 2007 | 81 | 0.070 |
Why?
|
| Humans | 7 | 2023 | 123146 | 0.060 |
Why?
|
| Adolescent | 4 | 2021 | 19093 | 0.060 |
Why?
|
| Pyridostigmine Bromide | 1 | 2021 | 13 | 0.050 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.050 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2020 | 23 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 76 | 0.050 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.050 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 22 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2021 | 125 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2020 | 92 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2020 | 52 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 273 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 51 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 4705 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 161 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2021 | 13878 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 4221 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 90 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 231 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 149 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 44 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 268 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 61 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 88 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2021 | 378 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 123 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16000 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 256 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 759 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 644 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 713 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 847 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 939 | 0.030 |
Why?
|
| Female | 4 | 2021 | 65443 | 0.030 |
Why?
|
| Child | 3 | 2021 | 24221 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 866 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3526 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 937 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 550 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2023 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1760 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 1480 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2799 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 1604 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1041 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1019 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2529 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2585 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 2946 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8104 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 8864 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12116 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 29029 | 0.010 |
Why?
|